gabexate has been researched along with Disease Models, Animal in 33 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Camostat mesilate (CM), an oral protease inhibitor, has been used clinically for the treatment of chronic pancreatitis in Japan." | 7.73 | Camostat mesilate attenuates pancreatic fibrosis via inhibition of monocytes and pancreatic stellate cells activity. ( Arita, Y; Fujimori, N; Gibo, J; Hisano, T; Inoue, M; Ito, T; Kawabe, K; Nawata, H; Oono, T, 2005) |
| "Camostat has a beneficial effect on pancreatic fibrosis induced by the administration of a SOD inhibitor, which inhibits the proliferation and activation of PSC." | 7.73 | Camostat, an oral trypsin inhibitor, reduces pancreatic fibrosis induced by repeated administration of a superoxide dismutase inhibitor in rats. ( Emori, Y; Ichimura, M; Koide, N; Matsumura, N; Mizushima, T; Ochi, K; Shinji, T; Shirahige, A; Tanimoto, M; Tanioka, H, 2005) |
| "An oral protease inhibitor, camostat mesilate (CM) has been used clinically for chronic pancreatitis (CP) in Japan, but it lacks enough scientific evidence of its effectiveness." | 7.71 | Effect of camostat mesilate on the expression of pancreatitis-associated protein (PAP), p8, and cytokines in rat spontaneous chronic pancreatitis. ( Iovanna, JL; Motoo, Y; Sawabu, N; Su, SB; Xie, MJ, 2001) |
| "An experimental model of chronic pancreatitis was induced by a retrograde injection of a viscous solution consisting of zein-oleic acid-linoleic acid (0." | 7.70 | Pathophysiologic studies of experimental chronic pancreatitis in rats induced by injection of zein-oleic acid-linoleic acid solution into the pancreatic duct. ( Kashima, K; Kataoka, K; Sakagami, J; Sasaki, T; Yorizumi, H, 1998) |
| "The effects of the cholecystokinin (CCK)-receptor antagonist proglumide, the protease inhibitor gabexate, and the hormones secretin and cholecystokinin-octapeptide (CCK-8) were studied in a model of acute hemorrhagic pancreatitis induced by feeding mice a choline-deficient, ethionine-supplemented (CDE) diet." | 7.67 | Beneficial effects of cholecystokinin-receptor blockade and inhibition of proteolytic enzyme activity in experimental acute hemorrhagic pancreatitis in mice. Evidence for cholecystokinin as a major factor in the development of acute pancreatitis. ( Ferrell, LD; Grendell, JH; Liddle, RA; Niederau, C, 1986) |
| "This study examined the effects of GM on hepatic encephalopathy in rats with acute and chronic liver failure." | 5.36 | Lack of therapeutic effects of gabexate mesilate on the hepatic encephalopathy in rats with acute and chronic hepatic failure. ( Chan, CY; Chang, CC; Hsu, CY; Huang, HC; Huo, TI; Lee, FY; Lee, SD; Lin, HC; Teng, TH; Wang, SS, 2010) |
| "Antiprotease has long been used for the treatment of acute pancreatitis, although its effects and mechanism have not been fully elucidated." | 5.29 | The effect of gabexate mesilate on pancreatic and hepatic microcirculation in acute experimental pancreatitis in rats. ( Chen, HM; Chen, MF; Hwang, TL, 1996) |
| " However, the effects of the serine protease inhibitors nafamostat mesilate (FUT), gabexate mesilate (FOY), and ulinastatin (UTI) on a long-term challenged mouse model of chronic asthma are unclear." | 3.80 | The effect of serine protease inhibitors on airway inflammation in a chronic allergen-induced asthma mouse model. ( Chao, YP; Chiang, CJ; Kao, ST; Lin, CC; Lin, J; Lin, LJ; Wang, SD, 2014) |
| "Camostat mesilate (CM), an oral protease inhibitor, has been used clinically for the treatment of chronic pancreatitis in Japan." | 3.73 | Camostat mesilate attenuates pancreatic fibrosis via inhibition of monocytes and pancreatic stellate cells activity. ( Arita, Y; Fujimori, N; Gibo, J; Hisano, T; Inoue, M; Ito, T; Kawabe, K; Nawata, H; Oono, T, 2005) |
| "Camostat has a beneficial effect on pancreatic fibrosis induced by the administration of a SOD inhibitor, which inhibits the proliferation and activation of PSC." | 3.73 | Camostat, an oral trypsin inhibitor, reduces pancreatic fibrosis induced by repeated administration of a superoxide dismutase inhibitor in rats. ( Emori, Y; Ichimura, M; Koide, N; Matsumura, N; Mizushima, T; Ochi, K; Shinji, T; Shirahige, A; Tanimoto, M; Tanioka, H, 2005) |
| "An oral protease inhibitor, camostat mesilate (CM) has been used clinically for chronic pancreatitis (CP) in Japan, but it lacks enough scientific evidence of its effectiveness." | 3.71 | Effect of camostat mesilate on the expression of pancreatitis-associated protein (PAP), p8, and cytokines in rat spontaneous chronic pancreatitis. ( Iovanna, JL; Motoo, Y; Sawabu, N; Su, SB; Xie, MJ, 2001) |
| "An experimental model of chronic pancreatitis was induced by a retrograde injection of a viscous solution consisting of zein-oleic acid-linoleic acid (0." | 3.70 | Pathophysiologic studies of experimental chronic pancreatitis in rats induced by injection of zein-oleic acid-linoleic acid solution into the pancreatic duct. ( Kashima, K; Kataoka, K; Sakagami, J; Sasaki, T; Yorizumi, H, 1998) |
| "The effect of methylcarbonylmethyl 2(S)-14-(4-guanidino-benzoyloxy) phenyl] propionate methanesulfonate (TT-S24) on experimental pancreatitis in rats was examined in comparison with that of camostat." | 3.70 | Effect of methylcarbonylmethyl 2(S)-[4-(4-guanidino-benzoyloxy)phenyl] propionate methanesulfonate (TT-S24) on experimental pancreatitis in rats. ( Abe, S; Kamei, C; Tagami, H; Tanaka, I; Yoshida, Y, 1998) |
| "The effect of oral administration of protease inhibitor (camostat) on pancreatic morphology and exocrine function (conscious rat model) was investigated using WBN/Kob rats with spontaneous chronic pancreatitis." | 3.69 | Effect of oral administration of protease inhibitor on pancreatic exocrine function in WBN/Kob rats with chronic pancreatitis. ( Atomi, Y; Kobori, O; Kuroda, A; Muto, T; Sugiyama, M; Wada, N, 1996) |
| "Effects of a new cholecystokinin (CCK)A-receptor antagonist, T-0632 [sodium (S)-1-(2-fluorophenyl)-2, 3-dihydro-3-[(3-isoquinolinylcarbonyl) amino]-6-methoxy-2-oxo-1H-indole-3-propanoate], on caerulein-induced and pancreatic duct ligation-induced pancreatitis models were studied and compared with the CCKA-receptor antagonist loxiglumide and the orally active protease inhibitor camostate, respectively." | 3.69 | Effect of T-0632, a cholecystokininA receptor antagonist, on experimental acute pancreatitis. ( Endo, T; Kume, E; Nagasaki, M; Shikano, T; Taniguchi, H; Yomota, E, 1997) |
| "The effects of the cholecystokinin (CCK)-receptor antagonist proglumide, the protease inhibitor gabexate, and the hormones secretin and cholecystokinin-octapeptide (CCK-8) were studied in a model of acute hemorrhagic pancreatitis induced by feeding mice a choline-deficient, ethionine-supplemented (CDE) diet." | 3.67 | Beneficial effects of cholecystokinin-receptor blockade and inhibition of proteolytic enzyme activity in experimental acute hemorrhagic pancreatitis in mice. Evidence for cholecystokinin as a major factor in the development of acute pancreatitis. ( Ferrell, LD; Grendell, JH; Liddle, RA; Niederau, C, 1986) |
| "This study examined the effects of GM on hepatic encephalopathy in rats with acute and chronic liver failure." | 1.36 | Lack of therapeutic effects of gabexate mesilate on the hepatic encephalopathy in rats with acute and chronic hepatic failure. ( Chan, CY; Chang, CC; Hsu, CY; Huang, HC; Huo, TI; Lee, FY; Lee, SD; Lin, HC; Teng, TH; Wang, SS, 2010) |
| "Gabexate mesilate treatment significantly decreased the elevation of serum transaminase levels and improved liver histology 24 h after the administration of CCl4 (0." | 1.33 | Gabexate mesilate, a synthetic protease inhibitor, attenuates carbon tetrachloride-induced liver injury in rats. ( Goto, T; Kataoka, E; Lin, JG; Mikami, K; Miura, K; Ohshima, S; Segawa, D; Shibuya, T; Watanabe, D; Watanabe, S; Yoneyama, K, 2005) |
| "The roles of TNFalpha and IL-6 in liver reperfusion injury were not clear, though TNFalpha might have had an effect during the early phase." | 1.30 | Effect of protease inhibitor on ischemia-reperfusion injury to rat liver. ( Choe, KJ; Ha, J; Jung, SE; Kim, SJ; Lee, JE; Noh, DY; Oh, SK; Youn, YK; Yun, IJ, 1999) |
| "Antiprotease has long been used for the treatment of acute pancreatitis, although its effects and mechanism have not been fully elucidated." | 1.29 | The effect of gabexate mesilate on pancreatic and hepatic microcirculation in acute experimental pancreatitis in rats. ( Chen, HM; Chen, MF; Hwang, TL, 1996) |
| "Acute respiratory failure after hepatic resection, especially in case of concomitant liver dysfunction, is the most troublesome postoperative complication." | 1.27 | [Acute respiratory failure after hepatic resection in canine biliary obstruction model]. ( Sodeyama, M, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (18.18) | 18.7374 |
| 1990's | 12 (36.36) | 18.2507 |
| 2000's | 6 (18.18) | 29.6817 |
| 2010's | 7 (21.21) | 24.3611 |
| 2020's | 2 (6.06) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM | 1 |
| Yasgar, A | 1 |
| Teramoto, T | 1 |
| Lee, MH | 1 |
| Dorjsuren, D | 1 |
| Eastman, RT | 1 |
| Malik, N | 1 |
| Zakharov, AV | 1 |
| Li, W | 1 |
| Bachani, M | 1 |
| Brimacombe, K | 1 |
| Steiner, JP | 1 |
| Hall, MD | 1 |
| Balasubramanian, A | 1 |
| Jadhav, A | 1 |
| Padmanabhan, R | 1 |
| Simeonov, A | 1 |
| Nath, A | 1 |
| Uno, Y | 1 |
| Lin, CC | 1 |
| Lin, LJ | 1 |
| Wang, SD | 1 |
| Chiang, CJ | 1 |
| Chao, YP | 1 |
| Lin, J | 1 |
| Kao, ST | 1 |
| Jia, D | 1 |
| Yamamoto, M | 1 |
| Otsuki, M | 2 |
| Narita, Y | 1 |
| Ueda, M | 1 |
| Uchimura, K | 1 |
| Kakizoe, Y | 1 |
| Miyasato, Y | 1 |
| Mizumoto, T | 1 |
| Morinaga, J | 1 |
| Hayata, M | 1 |
| Nakagawa, T | 1 |
| Adachi, M | 1 |
| Miyoshi, T | 1 |
| Sakai, Y | 1 |
| Kadowaki, D | 1 |
| Hirata, S | 1 |
| Mukoyama, M | 1 |
| Kitamura, K | 1 |
| Yamada, Y | 1 |
| Ueda, Y | 1 |
| Nakamura, A | 1 |
| Kanayama, S | 1 |
| Tamura, R | 1 |
| Hashimoto, K | 1 |
| Matsumoto, T | 1 |
| Ishii, R | 1 |
| Hsu, CY | 1 |
| Lee, FY | 1 |
| Huo, TI | 1 |
| Chan, CY | 1 |
| Huang, HC | 1 |
| Lin, HC | 1 |
| Chang, CC | 1 |
| Teng, TH | 1 |
| Wang, SS | 1 |
| Lee, SD | 1 |
| Hoffmeister, C | 1 |
| Trevisan, G | 1 |
| Rossato, MF | 1 |
| de Oliveira, SM | 1 |
| Gomez, MV | 1 |
| Ferreira, J | 1 |
| Uomo, G | 1 |
| Gibo, J | 1 |
| Ito, T | 1 |
| Kawabe, K | 1 |
| Hisano, T | 1 |
| Inoue, M | 1 |
| Fujimori, N | 1 |
| Oono, T | 1 |
| Arita, Y | 1 |
| Nawata, H | 1 |
| Mikami, K | 1 |
| Goto, T | 1 |
| Miura, K | 1 |
| Ohshima, S | 1 |
| Yoneyama, K | 1 |
| Lin, JG | 1 |
| Watanabe, D | 1 |
| Segawa, D | 1 |
| Kataoka, E | 1 |
| Shibuya, T | 1 |
| Watanabe, S | 1 |
| Emori, Y | 1 |
| Mizushima, T | 1 |
| Matsumura, N | 1 |
| Ochi, K | 1 |
| Tanioka, H | 1 |
| Shirahige, A | 1 |
| Ichimura, M | 1 |
| Shinji, T | 1 |
| Koide, N | 1 |
| Tanimoto, M | 1 |
| Chen, CF | 1 |
| Wang, D | 1 |
| Lin, HI | 1 |
| Shen, CY | 1 |
| Yang, NP | 1 |
| Nagashio, Y | 1 |
| Kosaki, G | 1 |
| Kambayashi, J | 1 |
| Imaoka, S | 1 |
| Okumura, Y | 1 |
| Inoue, H | 1 |
| Fujiyama, Y | 1 |
| Bamba, T | 1 |
| Watanapa, P | 1 |
| Williamson, RC | 1 |
| Kaga, N | 1 |
| Katsuki, Y | 1 |
| Obata, M | 1 |
| Shibutani, Y | 1 |
| Sugiyama, M | 1 |
| Kobori, O | 1 |
| Atomi, Y | 1 |
| Wada, N | 1 |
| Kuroda, A | 1 |
| Muto, T | 1 |
| Lee, MG | 1 |
| Kim, KH | 1 |
| Park, KY | 1 |
| Kim, JS | 1 |
| Chen, HM | 1 |
| Hwang, TL | 1 |
| Chen, MF | 1 |
| Taniguchi, H | 1 |
| Yomota, E | 1 |
| Kume, E | 1 |
| Shikano, T | 1 |
| Endo, T | 1 |
| Nagasaki, M | 1 |
| Kataoka, K | 1 |
| Sasaki, T | 1 |
| Yorizumi, H | 1 |
| Sakagami, J | 1 |
| Kashima, K | 1 |
| Tagami, H | 1 |
| Abe, S | 1 |
| Yoshida, Y | 1 |
| Tanaka, I | 1 |
| Kamei, C | 1 |
| Jung, SE | 1 |
| Yun, IJ | 1 |
| Youn, YK | 1 |
| Lee, JE | 1 |
| Ha, J | 1 |
| Noh, DY | 1 |
| Kim, SJ | 1 |
| Oh, SK | 1 |
| Choe, KJ | 1 |
| Su, SB | 1 |
| Motoo, Y | 1 |
| Iovanna, JL | 1 |
| Xie, MJ | 1 |
| Sawabu, N | 1 |
| Kazama, M | 1 |
| Kobayashi, K | 1 |
| Tahara, C | 1 |
| Miyajima, Y | 1 |
| Endo, Y | 1 |
| Tanaka, H | 1 |
| Nakatani, T | 1 |
| Tajimi, K | 1 |
| Kamiyasu, K | 1 |
| Awata, H | 1 |
| Inoshiri, S | 1 |
| Doi, A | 1 |
| Omawari, N | 1 |
| Okegawa, T | 1 |
| Kawasaki, A | 1 |
| Shinomiya, K | 1 |
| Tanaka, M | 1 |
| Suzuki, Y | 1 |
| Niederau, C | 2 |
| Liddle, RA | 1 |
| Ferrell, LD | 2 |
| Grendell, JH | 2 |
| Wisner, JR | 1 |
| Renner, IG | 1 |
| Redmond, HP | 1 |
| Leahy, AL | 1 |
| Keane, FB | 1 |
| Tanner, WA | 1 |
| Sodeyama, M | 1 |
| Kondo, M | 1 |
| Furukawa, Y | 1 |
| Yoshikawa, T | 1 |
| Kato, H | 1 |
| Sugino, S | 1 |
3 reviews available for gabexate and Disease Models, Animal
| Article | Year |
|---|---|
Action of antiproteases on fibrosis in experimental chronic pancreatitis.
Topics: Animals; Disease Models, Animal; Esters; Fibrosis; Gabexate; Guanidines; Pancreatitis, Chronic; Prot | 2007 |
Experimental pancreatic hyperplasia and neoplasia: effects of dietary and surgical manipulation.
Topics: Animals; Cricetinae; Diet; Disease Models, Animal; Energy Intake; Esters; Flour; Gabexate; Glycine m | 1993 |
[Complement and disseminated intravascular coagulation].
Topics: Animals; Antigen-Antibody Complex; Complement Inactivator Proteins; Complement System Proteins; Dise | 1985 |
30 other studies available for gabexate and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr | 2020 |
Camostat mesilate therapy for COVID-19.
Topics: Animals; Coronavirus Infections; COVID-19; Disease Models, Animal; Esters; Gabexate; Guanidines; Jap | 2020 |
The effect of serine protease inhibitors on airway inflammation in a chronic allergen-induced asthma mouse model.
Topics: Allergens; Animals; Asthma; Benzamidines; Disease Models, Animal; Gabexate; Glycoproteins; Guanidine | 2014 |
Effect of endogenous cholecystokinin on the course of acute pancreatitis in rats.
Topics: Administration, Oral; Animals; Biomarkers; Bombesin; Cell Proliferation; Cholecystokinin; Disease Mo | 2015 |
Combination therapy with renin-angiotensin-aldosterone system inhibitor telmisartan and serine protease inhibitor camostat mesilate provides further renoprotection in a rat chronic kidney disease model.
Topics: Aldosterone; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazol | 2016 |
Immediate-type allergic and protease-mediated reactions are involved in scratching behaviour induced by topical application of Dermatophagoides farinae extract in NC/Nga mice.
Topics: Animals; Antibodies; Antipruritics; Behavior, Animal; Capillary Permeability; Chlorpheniramine; Comp | 2018 |
Lack of therapeutic effects of gabexate mesilate on the hepatic encephalopathy in rats with acute and chronic hepatic failure.
Topics: Animals; Anti-Inflammatory Agents; Biomarkers; Blood Pressure; Chronic Disease; Common Bile Duct; Di | 2010 |
Role of TRPV1 in nociception and edema induced by monosodium urate crystals in rats.
Topics: Acrylamides; Anilides; Animals; Anti-Allergic Agents; Anti-Asthmatic Agents; Antioxidants; Bridged B | 2011 |
Lesson from acute experimental pancreatitis: multidrug strategies is effective than single-target therapy.
Topics: Acetylcysteine; Animals; Antibodies, Monoclonal; Arginine; Disease Models, Animal; Drug Therapy, Com | 2012 |
Camostat mesilate attenuates pancreatic fibrosis via inhibition of monocytes and pancreatic stellate cells activity.
Topics: Animals; Cell Proliferation; Chemokine CCL2; Disease Models, Animal; Dose-Response Relationship, Dru | 2005 |
Gabexate mesilate, a synthetic protease inhibitor, attenuates carbon tetrachloride-induced liver injury in rats.
Topics: Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Disea | 2005 |
Camostat, an oral trypsin inhibitor, reduces pancreatic fibrosis induced by repeated administration of a superoxide dismutase inhibitor in rats.
Topics: Administration, Oral; Animals; Disease Models, Animal; Ditiocarb; Drug Administration Schedule; Este | 2005 |
Translocation of pancreatic juice after ischemia and reperfusion of the intestines and the effects of gabexate mesilate (FOY) in rats.
Topics: Animals; Disease Models, Animal; Gabexate; Intestines; Male; Mesenteric Artery, Superior; Pancreatic | 2007 |
Application of a synthetic serine protease inhibitor in the treatment of DIC.
Topics: Animals; Chemical Phenomena; Chemistry; Disease Models, Animal; Disseminated Intravascular Coagulati | 1983 |
Effects of serine protease inhibitors on accumulation of polymorphonuclear leukocytes in the lung induced by acute pancreatitis in rats.
Topics: Acute Disease; Animals; Cell Adhesion; Cell Movement; Cells, Cultured; Disease Models, Animal; Endot | 1995 |
Repeated administration of low-dose lipopolysaccharide induces preterm delivery in mice: a model for human preterm parturition and for assessment of the therapeutic ability of drugs against preterm delivery.
Topics: Animals; Disease Models, Animal; Escherichia coli; Female; Gabexate; Glycoproteins; Humans; Indometh | 1996 |
Effect of oral administration of protease inhibitor on pancreatic exocrine function in WBN/Kob rats with chronic pancreatitis.
Topics: Administration, Oral; Animals; Cholecystokinin; Chronic Disease; Disease Models, Animal; Esters; Gab | 1996 |
Evaluation of anti-influenza effects of camostat in mice infected with non-adapted human influenza viruses.
Topics: Adaptation, Physiological; Amantadine; Animals; Antiviral Agents; Cell Line; Disease Models, Animal; | 1996 |
The effect of gabexate mesilate on pancreatic and hepatic microcirculation in acute experimental pancreatitis in rats.
Topics: Acute Disease; Animals; Ceruletide; Disease Models, Animal; Endothelium, Vascular; Gabexate; Leukocy | 1996 |
Effect of T-0632, a cholecystokininA receptor antagonist, on experimental acute pancreatitis.
Topics: Acute Disease; Amylases; Animals; Ceruletide; Disease Models, Animal; Dogs; Esters; Female; Gabexate | 1997 |
Pathophysiologic studies of experimental chronic pancreatitis in rats induced by injection of zein-oleic acid-linoleic acid solution into the pancreatic duct.
Topics: Amylases; Animals; Blood Glucose; Body Weight; Chronic Disease; Disease Models, Animal; Esters; Gabe | 1998 |
Effect of methylcarbonylmethyl 2(S)-[4-(4-guanidino-benzoyloxy)phenyl] propionate methanesulfonate (TT-S24) on experimental pancreatitis in rats.
Topics: Amylases; Animals; Ceruletide; Disease Models, Animal; Esters; Gabexate; Guanidines; Male; Pancreati | 1998 |
Effect of protease inhibitor on ischemia-reperfusion injury to rat liver.
Topics: Animals; Catalase; Disease Models, Animal; Female; Gabexate; Interleukin-6; Lipid Peroxidation; Live | 1999 |
Effect of camostat mesilate on the expression of pancreatitis-associated protein (PAP), p8, and cytokines in rat spontaneous chronic pancreatitis.
Topics: Acute-Phase Proteins; Animals; Antigens, Neoplasm; Basic Helix-Loop-Helix Transcription Factors; Bio | 2001 |
[Improving effect of the synthetic protease inhibitor E-3123 on experimental DIC in dogs].
Topics: Animals; Blood Coagulation Tests; Disease Models, Animal; Disseminated Intravascular Coagulation; Do | 1992 |
[Effects of FOY-305 on post-operative reflux esophagitis in rats (I). Effects of FOY-305 on reflux esophagitis after total gastrectomy in rats].
Topics: Alginates; Animals; Body Weight; Cimetidine; Disease Models, Animal; Esophagitis, Peptic; Esters; Ga | 1991 |
Beneficial effects of cholecystokinin-receptor blockade and inhibition of proteolytic enzyme activity in experimental acute hemorrhagic pancreatitis in mice. Evidence for cholecystokinin as a major factor in the development of acute pancreatitis.
Topics: Acute Disease; Amylases; Animals; Cholecystokinin; Choline Deficiency; Disease Models, Animal; Ethio | 1986 |
Gabexate mesilate (FOY) protects against ceruletide-induced acute pancreatitis in the rat.
Topics: Acute Disease; Amylases; Animals; Ceruletide; Disease Models, Animal; Gabexate; Guanidines; Infusion | 1987 |
Effect of FOY-305 (Camostate) on severe acute pancreatitis in two experimental animal models.
Topics: Acute Disease; Animals; Disease Models, Animal; Esters; Gabexate; Guanidines; Pancreatitis; Rats; Ra | 1989 |
[Acute respiratory failure after hepatic resection in canine biliary obstruction model].
Topics: Acute Disease; Animals; Body Water; Capillary Permeability; Cholestasis; Disease Models, Animal; Dog | 1988 |